People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FLYR, Inc. | — | Other | Series D+ | $131.7M | $1.5B | 2021 |
| Nuclein, LLC | — | Biotechnology | Series A | $34.5M | $48.3M | 2023 |
| Renew Lending, Inc. | — | Other | Pre-Seed | $250K | $5.8M | 2011 |
William Cunningham at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Cunningham on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Kimmel | 1 | 13 |
| Ullas Naik | 1 | 12 |
| Sanjay Chandra | 1 | 11 |
| John Butler | 1 | 5 |
| Joseph Cunningham | 1 | 4 |
| Phin Upham | 1 | 3 |
| Martin Edelman | 1 | 3 |
| Toby Stuart | 1 | 2 |
| H. David Shockley | 1 | 2 |
| Pankaj Shah | 1 | 2 |
| Andrew Jing | 1 | 1 |
| Cole Woolsey | 1 | 1 |
| Alexander Mans | 1 | 1 |
| Jean Tripier | 1 | 1 |
| Alan Blake | 1 | 1 |
| Richard Crockett | 1 | 1 |
| Douglas Bryant | 1 | 1 |
| Walter David Narajowski | 1 | 1 |
| Jeffrey David Stukuls | 1 | 1 |
| Walter Narajowski | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.